SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 202.04-1.9%1:55 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Machaon who wrote (23275)7/16/1998 9:03:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
Speaking of strong news, LGND was mentioned a couple of times in Bear Stearn's Biotech Watch which came out yesterday.

Under "Regulatory Watch", LGND priority review for Topical Panretin was discussed. Since the NDA was filed on May 26, 1998, a late November approval is anticipated. BS expects a full launch in 1Q, 1999, rather than the last quarter of this year because of the holiday season.

The G-CSF mimic is discussed under the "Clinical Watch" section. It's competition with Neupogen was mentioned and the discussion closed with "Preclinical data presented in the Science article indicate that the new molecule stimulates neutrophil production in a mouse model."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext